UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: SoluCortef100mgpulvervatskainj-SE-PLC-MPD-BBDL

Solu-Cortef 100 mg pulver och vätska till injektionsvätska, lösning

MPID: SE-100001390-00005561
EURDID: 10855

Full name: Solu-Cortef 100 mg pulver och vätska till injektionsvätska, lösning

- Invented name part: Solu-Cortef

- Strength part: 100 mg

- Pharmaceutical dose form part: pulver och vätska till injektionsvätska, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Powder and solvent for solution for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000096043 hydrocortisone

Marketing Authorisation 1 of 1

Authorisation number: MTnumber

Region: Kingdom of Sweden

Marketing authorisation holder: Pfizer AB

Identifier:

  • LOC-100005188

Status: Valid (1958-02-13)

Package 1 of 2

PCID:

Description:
Flaska, 100 mg + 2 ml (Act-O-Vial)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Cartridge

Package: 1 Box (Cardboard)

Containing: 1 Cartridge

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Cartridge

Ingredient

Role: Active

Substance: Hydrocortisone sodium succinate

Presentation strength: 134 milligram(s) / 1 Cartridge

Reference strength:
Hydrocortisone 100 milligram(s) / 1 Cartridge

Package 2 of 2

PCID:

Description:
Flaska, 25 x (100 mg + 2 ml) (Act-O-Vial)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 25 Cartridge

Package: 1 Box (Cardboard)

Containing: 25 Cartridge

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Cartridge

Ingredient

Role: Active

Substance: Hydrocortisone sodium succinate

Presentation strength: 134 milligram(s) / 1 Cartridge

Reference strength:
Hydrocortisone 100 milligram(s) / 1 Cartridge

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Intramuscular use

Ingredients:

Ingredient

Role: Active

Substance: Hydrocortisone sodium succinate

Presentation strength: 134 milligram(s) / 1 Cartridge

Reference strength:
Hydrocortisone 100 milligram(s) / 1 Cartridge